Search
Searching Content indexed under Life Sciences, Biotechnology & Nanotechnology by Bruce Sokler ordered by Published Date Descending.
Links to Result pages
 
1  
 
Title
Country
Organisation
Author
Date
1
Third Circuit Reinstates $67 Million Antitrust "Refusal To Deal" Suit Against Blues
The Third Circuit reinstated an antitrust suit brought by a medical device seller that alleged Blue Cross Blue Shield Association ...
United States
5 Sep 2018
2
FTC Looks to Accelerate Oncology Drug Growth by Requiring Novartis to Divest Two Protein Inhibitors in Its Clinical Development Pipeline
The Federal Trade Commission ("FTC") on Monday completed its review of Novartis AG’s ("Novartis") proposed $16 billion acquisition of GlaxoSmithKline’s ("GSK") oncology drug portfolio with an announced consent decree that requires limited divestitures of BRAF- and MEK-inhibitor drugs used to treat melanoma, ovarian, colorectal, non-small cell lung, and other cancers.
United States
2 Mar 2015
3
DOJ Releases Electrifying New Guidance On Standard-Essential Patent Policy
The Department of Justice continued its multi-pronged defense of standards-setting organizations (SSOs) who adopt patent policies to prevent hold-up during licensing negotiations.
United States
12 Feb 2015
4
Is 4-3 The New 3-2? FTC Continues To Target Pharmaceutical Mergers
The FTC has often stated that merger analysis requires more than a simplistic determination that high market concentration leads to anticompetitive effects.
United States
17 Apr 2014
Links to Result pages
 
1